T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Amneal Pharmaceuticals
AMRX
$6.15B
| $246M | 0.04% |
11,070,504
+11,027,092
| +25,401% | +$232M |
|
427
Adobe
ADBE
$103B
| $246M | 0.04% |
909,963
-10,840
| -1% | -$2.79M |
|
|
TXNM
428
TXNM Energy Inc
TXNM
$5.91B
| $245M | 0.04% |
6,205,183
-49,986
| -0.8% | -$1.96M |
|
429
Automatic Data Processing
ADP
$107B
| $244M | 0.04% |
1,620,640
-34,736
| -2% | -$4.91M |
|
430
PPG Industries
PPG
$25.5B
| $243M | 0.04% |
2,225,833
+340,940
| +18% | +$37.2M |
|
431
Lowe's Companies
LOW
$121B
| $243M | 0.04% |
2,113,741
+245,886
| +13% | +$25.6M |
|
|
HR
432
DELISTED
Healthcare Realty Trust Incorporated
HR
| $242M | 0.04% |
8,278,179
-314,471
| -4% | -$9.39M |
|
433
Equitable Holdings
EQH
$14.1B
| $241M | 0.04% |
11,234,973
+7,840,935
| +231% | +$172M |
|
434
Raymond James Financial
RJF
$34.9B
| $241M | 0.04% |
3,925,616
+412,367
| +12% | +$25.4M |
|
|
AJRD
435
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $241M | 0.04% |
7,087,276
+1,370,795
| +24% | +$45.7M |
|
436
Ollie's Bargain Outlet
OLLI
$4.73B
| $241M | 0.04% |
2,504,458
-120,509
| -5% | -$9.62M |
|
|
WPX
437
DELISTED
WPX Energy, Inc.
WPX
| $240M | 0.04% |
11,939,563
+276,725
| +2% | +$5.13M |
|
438
Ascendis Pharma A/S
ASND
$16.8B
| $240M | 0.04% |
3,381,796
+282,697
| +9% | +$19.5M |
|
439
Exelon
EXC
$46.6B
| $239M | 0.03% |
7,664,916
-281,434
| -4% | -$8.66M |
|
|
TIF
440
DELISTED
Tiffany & Co.
TIF
| $238M | 0.03% |
1,848,751
-71,896
| -4% | -$9.4M |
|
|
CUB
441
DELISTED
Cubic Corporation
CUB
| $238M | 0.03% |
3,261,039
+66,642
| +2% | +$4.77M |
|
442
Regeneron Pharmaceuticals
REGN
$82.2B
| $238M | 0.03% |
587,955
-115,930
| -16% | -$44.1M |
|
443
IBM
IBM
$222B
| $236M | 0.03% |
1,634,997
+75,321
| +5% | +$10.5M |
|
444
BioMarin Pharmaceuticals
BMRN
$13.6B
| $236M | 0.03% |
2,432,982
-88,501
| -4% | -$8.83M |
|
445
TJX Companies
TJX
$169B
| $236M | 0.03% |
4,210,218
-102,472
| -2% | -$5.26M |
|
446
Littelfuse
LFUS
$11.7B
| $235M | 0.03% |
1,186,760
+41,335
| +4% | +$9.09M |
|
|
ZEN
447
DELISTED
ZENDESK INC
ZEN
| $234M | 0.03% |
3,289,228
-30,491
| -0.9% | -$1.95M |
|
448
Dentsply Sirona
XRAY
$2.27B
| $232M | 0.03% |
6,149,550
+3,298,864
| +116% | +$137M |
|
449
Popular Inc
BPOP
$11.2B
| $232M | 0.03% |
4,524,799
-644,292
| -12% | -$32.1M |
|
450
Brown & Brown
BRO
$23.8B
| $231M | 0.03% |
7,796,790
+53,307
| +0.7% | +$1.58M |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.